|
|
S&P 500
7,563.63
+42.86 (+0.57%)
|
|
Dow Jones
50,668.97
+41.76 (+0.08%)
|
|
NASDAQ
26,917.47
+230.09 (+0.86%)
|
|
Market close: June 8, 2026
|
|
|
Stock Market Today
|
Dow, S&P 500, Nasdaq futures rise as AI trade takes
center stage
US stock futures moved higher on Tuesday as enthusiasm
around artificial intelligence continued to support
technology shares.
S&P 500 futures gained 0.4%, while Nasdaq 100 futures
rose 0.7%. Dow Jones Industrial Average futures added
0.2%.
Chip stocks were set to extend gains for a second
consecutive session. Micron Technology climbed nearly 4%
in premarket trading, while Nvidia and Broadcom also
moved higher.
The rally highlighted continued investor confidence in
AI-related companies despite concerns that persistent
inflation could lead the Federal Reserve to consider
another interest-rate hike later this year.
Yahoo
Finance
reports.
|
|
|
Image source: Lummi
|
|
|
EdgeUp
|
💽 Why is Micron stock gaining Tuesday?
Micron Technology shares rose in Tuesday's premarket
session as investors returned to semiconductor stocks
amid improving market sentiment and a broader rebound
across technology names.
Nasdaq futures gained 0.70%, while S&P 500 futures
advanced 0.44%.
The semiconductor sector also strengthened, with the
iShares Semiconductor ETF rising about 2% after posting
a roughly 6% gain in the previous session.
The broader recovery in chip stocks helped lift Micron
shares as investors renewed their focus on AI-related
and semiconductor companies.
Benzinga
reports.
|
|
🩺 Regentis Biomaterials to commence European surgeon
training for GelrinC. Stock soars in pre-market
Regentis Biomaterials announced plans to begin European
surgeon training activities in the third quarter of 2026
as it prepares for the commercial rollout of GelrinC in
Europe, where the product has CE Mark approval.
According to CEO Dr. Ehud Geller, the start of surgeon
training represents an important commercial milestone
for the company.
Regentis said physician training is a critical step in
its commercialization strategy, helping surgeons gain
experience and confidence with GelrinC ahead of broader
market adoption across Europe. TipRanks
reports.
|
|
🧬 GSK agrees to acquire Nuvalent for $124 per share;
stock surges in pre-market
GSK announced an agreement to acquire Nuvalent, a
Boston-based clinical-stage biopharmaceutical company
focused on targeted oncology therapies, in a deal valued
at $10.6 billion.
Under the agreement, GSK will pay $124 per share for
Nuvalent.
GSK said the acquisition aligns with its strategy of
acquiring assets with validated targets that address
efficacy and tolerability limitations of current
standard-of-care treatments.
The transaction includes three lung cancer products and
expands GSK's oncology pipeline through a single
acquisition. TipRanks
reports.
|
|
🏦 Treasury market is telling Kevin Warsh rates need
to be higher
The $31 trillion U.S. Treasury market is signaling that
interest rates may need to move higher, with traders
increasingly pricing in another Federal Reserve rate
hike.
Yields on policy-sensitive two-year Treasury notes have
climbed to their highest level in more than a year
following a series of stronger-than-expected economic
reports.
At around 4.15%, the two-year Treasury yield is trading
above the Federal Reserve's current policy range of 3.5%
to 3.75%, a gap that has persisted since March.
The move reflects growing market expectations that the
Fed could deliver at least one quarter-point rate
increase as soon as October.
Yahoo
Finance
reports.
|
|
💊 Weight-loss drug developers line up to tap
lucrative market as competition heats up
The weight-loss drug market continues to attract intense
competition as biotech and pharmaceutical companies seek
to challenge industry leaders Novo Nordisk and Eli
Lilly.
Analysts expect the global weight-loss drug sector to
generate approximately $150 billion in annual sales over
the next decade.
The market is increasingly shifting toward oral
treatments, with Eli Lilly becoming the second company
to receive approval for a weight-loss pill in April.
The growing demand for obesity treatments and the
convenience of pill-based therapies are driving
investment and innovation across the industry. Yahoo
Finance
reports
|
|
|
Join Us Live Today
|
|
Sharpen your trading skills with free trading education
in our weekly TradeZero Live Podcasts.
Tuesday, Jun 9 | 11:00 AM ET
How To Identify & Trade Rotation Zones for
Entries and
Exits with Bob Iaccino
|
Save Your
Seat
|
|
|
Caution Flags Are Rising — And SpaceX Mania Is One
of Them
|
with Richie Naso, a
Wall Street veteran of over 40 years and former member
of the NYSE.
|
Last week delivered a sharp reality check for the bulls.
The S&P 500 suffered its worst single day since October,
snapping a nine-week winning streak, while the Nasdaq
dropped nearly 5% as rising Treasury yields hammered
growth stocks.
The trigger was a stronger-than-expected jobs report —
good news for the economy, bad news for stocks. The
familiar equation played out fast: strong jobs pushed
yields higher, reduced expectations for Fed rate cuts,
and sent investors rushing for the exits in tech and
small caps.
What concerns me beyond the headline numbers is Citi's
Bear Market Checklist, now at its highest level since
the 2008 financial crisis, with the US market showing
11.5 out of 18 warning flags. Not a sell signal on its
own, but not something I am comfortable ignoring.
On the opportunity side, gold mining stocks have pulled
back hard — the VanEck Gold Miners ETF is down 24% from
its February high — and with buyers consistently
stepping in around $4,500 per ounce and J.P. Morgan
forecasting gold at $5,245 by 2027, the miners are worth
a serious look for those with conviction.
This week, the SpaceX IPO dominates the calendar,
expected to price at around $135 per share at a roughly
$1.8 trillion valuation. SpaceX is a world-class
company, but the speculative enthusiasm spilling into
lower-quality space-related names concerns me far more
than the IPO itself. When narrative starts outpacing
fundamentals, history suggests it is time to get more
selective and more defensive. I am proceeding with
extreme caution this week. Past performance is not
indicative of future results.
|
Read the full post
|
|
|
Top 5 Movers in Early Pre-Market
|
(All pricing and percent gains are based on Early
Pre-Market from 4:00 AM to 7:00 AM ET)
Stock Analysis reports.
|
1) CHAI: Core AI Holdings,
Inc.
Total gain: +437.81%
|
|
2) CCTG: CCSC Technology
International Holdings Limited
Total gain: 394.57%
|
|
3) AZI: Autozi Internet
Technology (Global) Ltd.
Total gain: +167.26%
|
|
4) RGNT: Regentis
Biomaterials Ltd.
Total gain: +155.47%
|
|
5) DAIC: CID HoldCo, Inc.
Total gain: +42.92%
|
|
|
Today’s Economic Dates
|
|
Time (ET)
|
Report
|
Period
|
|
6:00 AM
|
NFIB optimism index
|
May
|
|
8:30 AM
|
U.S. trade balance
|
April
|
|
10:00 AM
|
Existing home sales
|
May
|
|
View
more
|
|
|
Yesterday's Biggest Movers
|
|
The closing price of the top three market percent
gainers trading near or above $3 on
June 8.
|
All pricing and percent gains are based on regular
market trading hours from 9:30 AM to
4:00 PM ET
Stock Analysis reports.
|
1) SUNE:
SUNation Energy Inc.
Total gain: +420.35%
The company announced plans to invest approximately
$350 million in a 4.5
gigawatt solar cell manufacturing facility in
Laurens County, South Carolina,
which, together with the company's existing
approximately 1 gigawatt
nameplate operation in metro Atlanta, is expected to
bring total annual
nameplate cell capacity to more than 5.5 gigawatts
once fully online in 2027.
Globe
Newswire
reports.
|
|
2) NPT: Texxon
Holding Limited
Total gain: +283.72%
The stock appeared to be moving on no notable news.
|
|
3) SDOT: Sadot
Group Inc.
Total gain: +69.11%
The stock appeared to be moving on no notable news.
|
|
|
Refer a Friend & Earn Together
|
|
Did you know that it pays to invite your friends to
TradeZero?
|
|
When they fund a new account with us, you’ll both
receive $100 USD. T&Cs apply.
|
|
Learn
more
|
|
|
Today’s Notable Earnings
|
Estimate and Actual numbers represent Earnings Per Share in US
Dollars
|
|
|
EH
EHang Holdings
Q1 2026
|
Before Market Open
Estimate: -0.140
Actual: -0.140
|
|
|
|
SJM
JM Smucker
Q4 2026
|
Before Market Open
Estimate: 2.640
Actual: N/A
|
|
|
|
CBRL
Cracker Barrel Old
Q3 2026
|
After Market Close
Estimate: -0.460
Actual: N/A
|
|
View more
|
|
Enjoying the DailyEdge?
|
|
Recommend our 5-minute daily digest to a friend by
sharing
this
link.
|
|
|
Parting Thoughts
|
|
“The trick is not to learn to trust your gut
feelings, but rather to discipline yourself to
ignore them.”
|
|
– Daniel Kahneman
|
|
Sourced in: Thinking, Fast and
Slow — GoodReads.
|
|
|
|
TradeZero America, Inc., member of FINRA and
SIPC. Investing involves risk, including the
possible loss of principal.
The information in this newsletter
summarizes the latest market activity and
related news and are provided for
educational purposes only. Any trading
symbols displayed are for illustrative
purposes only and do not constitute a
recommendation by TradeZero to buy, sell, or
hold any investment. This material is not
intended to provide investment advice or to
take into account any individual’s financial
condition, investment objectives, or
requirements.
Stocks experiencing significant price
volatility may involve substantial risk.
Past performance is no guarantee of future
results.
Options trading is not suitable for all
investors as it can involve risk that may
expose investors to significant losses.
Please read the Characteristics and Risks of
Standardized Options, also known as the
Options Disclosure Document (ODD) at OCC.
Any trading strategies discussed are for
educational purposes only and should not be
construed as investment advice or a
recommendation.
Certain information herein has been obtained
from third-party sources believed to be
reliable; however, its accuracy or
completeness cannot be guaranteed. The views
and opinions expressed are those of the
author and do not necessarily reflect the
views or opinions of TradeZero, its
affiliates, or employees.
If you have any specific questions about
TradeZero's brokerage services, please reach
out to the TradeZero Broker Dealer servicing
your jurisdiction.
Copyright © TradeZero 2026. All rights
reserved.
|
|
|
|
